Concepedia

Angela M. Moseley

AM

Statistics

Publications

6

Citations

548

H-Index

6

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Angela M. Moseley is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, glycine receptors, and pharmacology.

Publications per year

1992–1994

6

Publications

6

4-Amido-2-carboxytetrahydroquinolines. Structure-activity relationships for antagonism at the glycine site of the NMDA receptor

Paul D. Leeson, Robert W. Carling, Kevin W. Moore et al. · Journal of Medicinal Chemistry · 1992 · 187 citations · Full text

, , +15

2-Carboxytetrahydroquinolines. Conformational and stereochemical requirements for antagonism of the glycine site on the N-methyl-D-aspartate (NMDA) receptor

Robert W. Carling, P D Leeson, Angela M. Moseley et al. · Journal of Medicinal Chemistry · 1992 · 100 citations

, , +13

3-Acyl-4-hydroxyquinolin-2(1H)-ones. Systemically active anticonvulsants acting by antagonism at the glycine site of the N-methyl-D-aspartate receptor complex

Michael Rowley, Paul D. Leeson, Graeme I. Stevenson et al. · Journal of Medicinal Chemistry · 1993 · 88 citations

, , +16

Anticonvulsant activity of glycine-site NMDA antagonists. 2. trans 2-carboxy-4-substituted tetrahydroquinolines.

Robert W. Carling, Paul D. Leeson, Angela M. Moseley et al. · Bioorganic & Medicinal Chemistry Letters · 1993 · 85 citations

, , +11

Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes.

S. Grimwood, Angela M. Moseley, Robert W. Carling et al. · Molecular Pharmacology · 1992 · 75 citations

, , +16

1–5 of 6